This study reports Rooibos-mediated silver nanoparticles (R-AgNPs) using the aqueous extract of Aspalathus linearis (Rooibos) and evaluates their multifunctional biological activities. The synthesis of R-AgNPs was indicated by a colour change from yellow to brown and a characteristic absorption peak at 432 nm. R-AgNPs were predominantly spherical, EDS confirmed the presence of silver, while XRD revealed a crystalline structure with an average particle size of 13.94 nm. The cytotoxic potential of R-AgNPs was assessed in SK-MEL-30 and L929 cells. Dose-dependent decreases in cell viability were observed, with respective IC₅₀ values of 17.32µg/mL and 30.07 µg/mL. Wound healing assays revealed that a dose of 6.25 µg/mL significantly increased fibroblast migration, resulting a 60.5-fold increase in wound closure at 24 hours, compared to a 22.6-fold in the control group. At 12 hours, R-AgNPs had accelerated cell migration by around fourfold. R-AgNPs increased TAS and reduced TOS and OSI in SK-MEL-30 cells, while maintaining near-normal oxidative balance in L929 cells. R-AgNPs exhibited concentration-dependent DPPH radical scavenging activity (25.87-65.91%) and strong α-glucosidase inhibition (31.86-100%), indicating their potential as antioxidants and antidiabetics. In conclusion, R-AgNPs exhibit selective cytotoxicity, antioxidant capacity, wound-healing promotion, and antidiabetic activity, highlighting their potential as safe, multifunctional nanotherapeutics for biomedical use.
No takes yet. Share an insight, caveat, or question.
Yeşilot et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: